1/ In the "gold rush" of medical AI, many platforms are racing to market. But in cardiology, the difference between a "good guess" and a "clinical standard" is the depth of the data behind it. Here is why data depth is the ultimate competitive differentiator. 👇

Heading to #NASCI2026? Join us Sunday, September 27, for our lunch symposium, "Changing the Care Pathway with CCTA + Heartflow: An Ongoing Case Study.” Drs. @CsFuss, Bradley Allen, and Paul Cremer will explore how AI-powered coronary CTA is transforming the modern cardiac care pathway. Through real-world cases and registry insights, this symposium will demonstrate practical applications of the Heartflow One platform to sharpen diagnostic precision, implement plaque-guided care, and optimize radiology-cardiology workflows. We hope to see you there!

Heartflow is proud to sponsor the 9th Annual @Heart_SCCT Cardiovascular Disease Prevention Symposium on Saturday, October 10, from 10:10 am–2:50 pm ET. Join this educational virtual event to understand the evolving landscape of preventive cardiology, novel therapies, and risk assessment tools to reduce cardiovascular risk. Register now: scct.org/page/PreventionSymp #CardiovascularHealth #Prevention #YesCCT

Mark your calendar! The Heartflow North UK Users' Meeting will take place in Manchester on Wednesday, September 30th. Cardiologists, radiologists, and imaging specialists from across the region will come together for a day of shared experience, practical insight, and discussion on where cardiovascular care is heading. Joining the faculty: @JonathonLeipsic, @fairbairn_tim, Alan Bagnall, @doctorradiology, @JWeirMcCall, and @NickCurzen. The meeting will take place at the Kimpton Clocktower Hotel from 10:00–16:00 BST (registration from 09:00). Register here, or speak to your Heartflow representative to find out more. eventbrite.co.uk/e/heartflow…

Congratulations to Dr. @YChatzizisis and his team at the @UMiamiHealth on enrolling their first patient in the NAVIGATE-PCI Registry. Heartflow PCI Navigator, the first and only integrated, AI-powered PCI planning tool, can help improve treatment plans with insights to streamline procedures with increased efficiency and clinical confidence. We're proud to be part of this advancement in precision heart care for patients in South Florida.

Photon-Counting CT is opening new possibilities for cardiac imaging. In a recent interview with @HCPLiveNews, Dr. @RonBlankstein discussed the technology’s potential, from improved resolution and visualization of calcified lesions to more detailed assessment of CAD. He also explored our latest data demonstrating consistent results with Heartflow Plaque Analysis across conventional and Photon-Counting CT, including plaque quantification, stenosis grading, and FFRct. Watch the full clip: hcplive.com/view/photon-coun…

Congratulations to Dr. @yadersandoval, Dr. @esbrilakis and their team at @MHIF_Heart on enrolling the first U.S. patient in the OPTIMAL P5 trial. Congratulations as well to Dr. @ColletCarlos and the @crfheart for leading this important research. At Heartflow, we're proud to support this research and the continued advancement of CT-guided PCI planning with Heartflow PCI Navigator, helping clinicians approach even the most complex cases with greater confidence and precision.

How reliably can coronary plaque be measured over time? Our recently released data demonstrated minimal variability between certified analysts and across repeat measurements, with 95% agreement when categorizing patients into total plaque volume-based stages. Dr. @RonBlankstein joined @HCPLiveNews to discuss the findings and why reproducibility matters for longitudinal disease tracking and assessing treatment response: hcplive.com/view/ai-cpa-plaq…

A CAC score of zero doesn’t always tell the full story. In an interview with @HCPLiveNews , Dr. @RonBlankstein discussed findings from a DECIDE Registry sub-study showing that 50% of symptomatic patients with a CAC score of zero were reclassified into higher-risk categories with total plaque volume-based Heartflow Plaque Staging. Hear from Dr. Blankstein on how looking beyond calcified plaque to overall plaque burden can help provide a more complete picture of cardiovascular risk: hcplive.com/view/total-plaqu…

Saints Hall of Famer Stan Brock recently joined the @iHeartMedia Seattle Voice podcast with Dr. Eugene Chang of CardioNow to share his experience participating in our GAMEFILM Registry. Stan opened up about why he wanted to take a closer look at his heart health, and the value of having information you can act on. Dr. Chang added his clinical perspective, discussing how earlier insight into CAD can help inform more personalized care. Hear their full conversation: iheart.com/podcast/1248-seat…$ #GAMEFILMRegistry #NFLAlumni #GridironGreats

Our Chief Medical Officer, Dr. Campbell Rogers, recently sat down with @IEEEembs to discuss a challenge that has shaped much of his career: finding and understanding CAD earlier so patients can receive more personalized care. The conversation touched on how far the field has come, the clinical evidence helping drive that progress, and newer advances like Heartflow PCI Navigator and our GAMEFILM Registry for former professional athletes. Read the full feature: embs.org/pulse/articles/bene…

Late-breaking data presented at #ESC2026 and simultaneously published in @JACCJournals show Heartflow FFRct Analysis reduced unnecessary invasive heart procedures by 44%. Results from the independent randomized FUSION trial demonstrate how adding Heartflow lesion-specific physiology to CCTA can help resolve diagnostic uncertainty and better inform cath lab referrals. Learn more: ir.heartflow.com/news-releas… #FFRct #YesCCT

Detecting narrowing was only half the story. New data at SCCT 2026 showed over 50% of patients with a "zero risk" calcium score have significant non-calcified plaque. Heartflow Plaque Analysis with Plaque Staging closes that gap for patients like Richard Smith, giving physicians like Dr. Patel a full 3D picture to guide treatment. Explore more: heartflow.com/patients-cad/p… #AIinHealthcare #YesCCT #PlaqueAnalysis

Our Chief Medical Officer, Dr. Campbell Rogers, joined Simon Hill on @theproof to talk about something cardiology has worked around for most of its history: treating coronary artery disease without being able to see and measure it. The conversation covers what a calcium score can and can't tell you, why low-attenuation plaque carries an outsized risk, and how measurement variability and validation of AI-powered plaque analysis tools should shape the interpretation of any single scan. Worth the listen. 🎧 Episode 426

You can't manage what you don't measure. Heartflow Plaque Analysis with Plaque Staging gives physicians a complete picture of plaque volume and composition in the coronary arteries, providing the insights needed to personalize care and help intervene before a cardiac event occurs. Hear more from Dr. Dharmesh Patel and Richard Smith about how Heartflow is transforming CAD from the leading cause of death into a condition that can be managed for life: heartflow.com/patients-cad/p… #AIinHealthcare #YesCCT #PlaqueAnalysis

Join us at #ASPC2026 for our Expert Theater, "Beyond Traditional Risk Scores: Integrating CCTA and Plaque Analysis for Personalized Cardiovascular Care," on July 31 at 12:30 p.m. in Grand Ballroom Salon F. Drs. Fatima Rodriguez and @RonBlankstein will discuss how CCTA + Heartflow Plaque Analysis can support more precise risk stratification and help inform personalized treatment strategies. No registration required. #AIinHealthcare #PlaqueAnalysis

Heading to #ASPC2026 in Scottsdale? Here’s what we have in store: Friday, July 31: Expert Theater from 12:30 - 1:15 p.m. in the Phoenician Grand Ballroom Salon F. Hear from Drs. Fatima Rodriguez and @RonBlankstein as they discuss how CCTA and Heartflow Plaque Analysis move beyond traditional risk scores to enable more personalized cardiovascular care. Throughout the meeting, stop by Booth 102 to connect with our team and take on the DECIDE challenge. See you there! #PlaqueAnalysis #AIinHealthcare

Total plaque volume predicts major cardiac events independent of stenosis. This finding, validated in 23K+ patients with up to 16 yrs of follow-up, is the foundation of Heartflow Plaque Staging. Learn more: heartflow.com/heartflow-one/… #YesCCT #AIinHealthcare

Heartflow Plaque Staging, the only staging tool based on total plaque volume, is now included with every Heartflow Plaque Analysis. Validated in more than 23,000 patients with up to 16 years of follow-up: heartflow.com/heartflow-one/… #YesCCT #AIinHealthcare

Nearly 50% of heart attack patients are labeled "low risk" by traditional risk assessments. This is a critical clinical gap. Discover how AI-powered Heartflow Plaque Analysis with Plaque Staging changes the paradigm: heartflow.com/heartflow-one/… #AIInHealthcare #YesCCT

The science that moved through San Diego was carried by exceptional people. Heartflow extends sincere thanks to the cardiovascular CT leaders who brought their expertise to the 21st Annual Scientific Meeting of the Society of Cardiovascular Computed Tomography. The field moves forward because of people who engage with this level of rigor and commitment. Thank you. @RonBlankstein @TaylorMHVIcard @MGRabbatMD #SCCT2026 #YesCCT #AIinHealthcare